Fig. 11From: Mesenchymal stem cell-derived exosomes protect against liver fibrosis via delivering miR-148a to target KLF6/STAT3 pathway in macrophagesSchematic diagram of MSC-EXOs to attenuate liver fibrosis in the fibrotic mice model. Liver fibrosis can be ameliorated by the infusion of MSC-EXOs, which deliver miR-148a to intrahepatic macrophages targeting KLF6 to inhibit the STAT3 signaling pathwayBack to article page